Mark For: INSMED™ trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 76308725 |
Mark Literal Elements | INSMED |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Mark Type | TRADEMARK. SERVICE MARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2005-07-26 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Norman J. Rich |
Law Office Assigned | L10 |
Employee Name | JOHNSON, AISHA CLARKE |
2001-09-05 | Application Filed |
2002-10-22 | Published |
2002-10-22 | Published for Opposition |
2005-07-26 | Location: INTENT TO USE SECTION |
2006-01-15 | Abandon |
2006-01-15 | Status: Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all docume |
2006-01-15 | Status: Dead/Abandoned |
2018-07-08 | Transaction Date |
Party: | INSMED, Inc. |
Address | 4581 Lake Brook Drive Glen Allen, VIRGINIA UNITED STATES 23060 |
Legal Entity Type | Corporation |
Legal Entity State | VIRGINIA |
(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical and biological preparations for clinical medical use, inoculations, and for use in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), metabolic syndrome; (syndrome X); polycystic ovary disease, infertility, hirsutism, hyperandrogenemia, severe burns, growth hormone insufficiency syndrome (GHIS also known as Laron Dwarfism), myotonic dystrophy, AIDS lipodystrophy, inflamatory disease, endocrine disease, reproductive disease, cancer, bacterial infection, viral infection, parasite infection, autoimmune disease, central nervous system disorders and neural tube defects; neutraceuticals for the treatment of type II diabetes, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), metabolic syndrome (Syndrome X), polycystic ovary disease, infertility, hirsutism, hyperandrogenemia and neural tube defects(ABANDONED)
IC 016. US 002 005 022 023 029 037 038 050. G & S: Prints; educational publications, namely, training manuals in the field of science and medicine; magazines in the field of science and medicine(ABANDONED)
IC 042. US 100 101. G & S: Chemical, scientific, medical and laboratory research
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 16 |
U.S. Codes: | 002,005,022,023,029,037,038,050 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical and biological preparations for clinical medical use, inoculations, and for use in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), metabolic syndrome; (syndrome X); polycystic ovary disease, infertility, hirsutism, hyperandrogenemia, severe burns, growth hormone insufficiency syndrome (GHIS also known as Laron Dwarfism), myotonic dystrophy, AIDS lipodystrophy, inflamatory disease, endocrine disease, reproductive disease, cancer, bacterial infection, viral infection, parasite infection, autoimmune disease, central nervous system disorders and neural tube defects; neutraceuticals for the treatment of type II diabetes, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), metabolic syndrome (Syndrome X), polycystic ovary disease, infertility, hirsutism, hyperandrogenemia and neural tube defects |
Description | Date | Proceeding Number |
---|---|---|
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2006-03-21 | |
ABANDONMENT - NO USE STATEMENT FILED | 2006-03-21 | 48372 |
SOU EXTENSION 5 GRANTED | 2005-07-14 | 70565 |
SOU EXTENSION 5 FILED | 2005-07-14 | 70565 |
PAPER RECEIVED | 2005-07-14 | |
SOU EXTENSION 4 GRANTED | 2005-02-10 | 76874 |
SOU EXTENSION 4 FILED | 2005-01-14 | 76874 |
PAPER RECEIVED | 2005-01-14 | |
SOU EXTENSION 3 GRANTED | 2004-08-16 | |
CASE FILE IN TICRS | 2004-07-30 | |
SOU EXTENSION 3 FILED | 2004-07-14 | |
PAPER RECEIVED | 2004-07-14 | |
ASSIGNED TO EXAMINER | 2004-04-26 | 76611 |
SOU EXTENSION 2 GRANTED | 2004-02-11 | |
SOU EXTENSION 2 FILED | 2004-01-14 | |
PAPER RECEIVED | 2004-01-14 | |
SOU EXTENSION 1 GRANTED | 2003-08-06 | |
SOU EXTENSION 1 FILED | 2003-07-14 | |
PAPER RECEIVED | 2003-07-14 | |
PAPER RECEIVED | 2003-04-09 | |
NOA MAILED - SOU REQUIRED FROM APPLICANT | 2003-01-14 | |
PUBLISHED FOR OPPOSITION | 2002-10-22 | |
NOTICE OF PUBLICATION | 2002-10-02 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2002-07-24 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2002-05-15 | |
NON-FINAL ACTION MAILED | 2001-11-15 | |
ASSIGNED TO EXAMINER | 2001-11-07 | 76934 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.